ALLOGENEIC STEM CELL TRANSPLANTATION
Clinical trials for ALLOGENEIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ALLOGENEIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo may keep leukemia at bay after transplant
Disease control OngoingThis study tests whether the drug ruxolitinib can lower the chance of leukemia returning after a stem cell transplant in older adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Participants take ruxolitinib as a maintenance therapy after transplant. The …
Matched conditions: ALLOGENEIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 17, 2026 08:04 UTC
-
Promising blood cancer trial pulled before starting
Disease control TerminatedThis study was designed to see if the drug ASTX727, taken alone or with donor immune cells, could help control blood cancers that return or persist after a stem cell transplant. It was planned for adults aged 18 to 75 with certain types of leukemia or myelodysplastic syndrome. Ho…
Matched conditions: ALLOGENEIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 08:00 UTC